These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1103 related articles for article (PubMed ID: 19237699)

  • 1. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
    Magaña SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
    Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
    Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH
    Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
    Eichel R; Meiner Z; Abramsky O; Gotkine M
    Arch Neurol; 2008 Feb; 65(2):267-71. PubMed ID: 18268199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS aquaporin-4 autoimmunity in children.
    McKeon A; Lennon VA; Lotze T; Tenenbaum S; Ness JM; Rensel M; Kuntz NL; Fryer JP; Homburger H; Hunter J; Weinshenker BG; Krecke K; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jul; 71(2):93-100. PubMed ID: 18509092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of NMO according to brain MRI findings].
    Shimizu Y
    Brain Nerve; 2010 Sep; 62(9):933-43. PubMed ID: 20844304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
    Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA
    Arch Neurol; 2006 Jul; 63(7):964-8. PubMed ID: 16831965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.
    Kim W; Kim SH; Lee SH; Li XF; Kim HJ
    Mult Scler; 2011 Sep; 17(9):1107-12. PubMed ID: 21543554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis and treatment of posterior reversible encephalopathy syndrome after neuromyelitis optica spectrum disorder: a case report and literature review.
    Yang B; Guo L; Yang X; Yu N
    BMC Neurol; 2022 Dec; 22(1):493. PubMed ID: 36539740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
    Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
    Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
    Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
    Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquaporin-4 autoantibodies in a paraneoplastic context.
    Pittock SJ; Lennon VA
    Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.